Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.
暂无分享,去创建一个
[1] J. Vauthey,et al. Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. , 2010, Seminars in oncology.
[2] K. Okita,et al. Management of hepatocellular carcinoma in Japan , 2006, Journal of Gastroenterology.
[3] M. Ducreux,et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy , 2004, Journal of surgical oncology.
[4] Christopher L Brace,et al. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? , 2009, Current problems in diagnostic radiology.
[5] J. Soto,et al. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. , 2001, Radiology.
[6] K. Abe,et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[7] Hirokazu Okada,et al. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version , 2013, Japanese Journal of Radiology.
[8] Michael Laniado,et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions , 2008, European Radiology.
[9] K. Bae,et al. Intravenous contrast medium administration and scan timing at CT: considerations and approaches. , 2010, Radiology.
[10] Steven A Curley,et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. , 2002, Archives of surgery.
[11] F. Lammert,et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.
[12] W. Chapman,et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.
[13] G. Gores,et al. Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.
[14] J. Ellis,et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. , 2013, Radiology.
[15] Osama Mawlawi,et al. Multimodality imaging: an update on PET/CT technology , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[16] T. Gruenberger,et al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? , 2011, European journal of radiology.
[17] J. Kellum,et al. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[18] T. Serrano,et al. Preoperative Staging of Patients with Liver Metastases of Colorectal Carcinoma. Does PET/CT Really Add Something to Multidetector CT? , 2011, Annals of Surgical Oncology.
[19] F. Rotellar,et al. Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified? , 2013, World journal of gastrointestinal oncology.
[20] M. Büchler,et al. [Surgical management of disappearing colorectal liver metastases]. , 2013, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[21] M. A. van den Bosch,et al. Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis , 2012, Annals of Surgical Oncology.
[22] N. Ackerman,et al. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. , 1969, Surgery.
[23] Steven G. Ross,et al. Application and Evaluation of a Measured Spatially Variant System Model for PET Image Reconstruction , 2010, IEEE Transactions on Medical Imaging.
[24] Hyeon Je Cho,et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[25] Masahiro Okada,et al. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow , 2010, European Radiology.
[26] P. Malfertheiner,et al. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. , 2010, Journal of gastrointestinal and liver diseases : JGLD.
[27] H. Hussain,et al. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. , 2013, Radiology.
[28] A. Scarsbrook,et al. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer. , 2011, Clinical radiology.
[29] F. Prat,et al. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures , 2000, Gut.
[30] Jeong Min Lee,et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma , 2010, Hepatology international.
[31] B. I. Choi,et al. Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability , 2000, Abdominal Imaging.
[32] S. Curley,et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. , 2007, Journal of the American College of Surgeons.
[33] C. Altehoefer,et al. Breathhold unenhanced and gadolinium-enhanced magnetic resonance tomography and magnetic resonance cholangiography in hilar cholangiocarcinoma , 2001, International Journal of Colorectal Disease.
[34] S. Tickoo,et al. Combined hepatocellular and cholangiocarcinoma , 2002, Cancer.
[35] Lihua Chen,et al. Comparison of MRI with liver-specific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: a meta-analysis of 15 direct comparative studies , 2013, Gut.
[36] T. Hwang,et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings , 2000, American Journal of Gastroenterology.
[37] R. Freeman,et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[38] N. Ackerman,et al. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. , 1970, Surgery.
[39] Jae Seung Kim,et al. Clinical Role of 18F-FDG PET-CT in Suspected and Potentially Operable Cholangiocarcinoma: A Prospective Study Compared With Conventional Imaging , 2008, The American Journal of Gastroenterology.
[40] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[41] Joon Koo Han,et al. Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Differentiating Small Hepatocellular Carcinomas (≤2 cm in Diameter) From Arterial Enhancing Pseudolesions: Special Emphasis on Hepatobiliary Phase Imaging , 2010, Investigative radiology.
[42] W. Jochum,et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. , 2006, Journal of hepatology.
[43] M. Gonen,et al. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.
[44] Carlo Catalano,et al. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging , 2013, European Radiology.
[45] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[46] P. Mittal,et al. Liver Imaging Reporting and Data System LI-RADS v2014 - A Pictorial Review of the Categories on CT and MRI , 2017 .
[47] N. Ackerman,et al. The blood supply of experimental liver metastases. V. Increased tumor perfusion with epinephrine. , 1980, American journal of surgery.
[48] Antonio Rodríguez-Fernández,et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[49] Ackerman Nb,et al. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. , 1970 .
[50] J. Konishi,et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. , 2001, AJR. American journal of roentgenology.
[51] Ann Harper,et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[52] Osamu Matsui,et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.
[53] S. Kumano,et al. Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT , 2012, European Radiology.
[54] T. Murakami,et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. , 2006, Radiology.
[55] Catherine Julié,et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] Steven S Raman,et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. , 2005, Radiology.
[57] Jesse S. Voss,et al. Primary sclerosing cholangitis with equivocal cytology: Fluorescence in situ hybridization and serum CA 19‐9 predict risk of malignancy , 2013, Cancer cytopathology.
[58] S. Curley,et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. , 2007, American journal of surgery.
[59] MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. , 2009, World journal of gastroenterology.
[60] D. Collins,et al. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. , 2012, The British journal of radiology.
[61] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[62] M. A. van den Bosch,et al. Accuracy of Multislice Liver CT and MRI for Preoperative Assessment of Colorectal Liver Metastases after Neoadjuvant Chemotherapy , 2011, Digestive Surgery.
[63] G. Gores,et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.
[64] P. Malfertheiner,et al. Hepatocellular carcinoma (HCC): a global perspective. , 2010, Journal of clinical gastroenterology.
[65] H. Bismuth,et al. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. , 1975, Surgery, gynecology & obstetrics.
[66] M. Cova,et al. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria , 2013, Abdominal Imaging.
[67] Markus Grube,et al. Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gd-EOB-DTPA: Role of Human Organic Anion Transporters , 2010, Drug Metabolism and Disposition.
[68] Jin‐Young Jang,et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. , 2006, Radiology.
[69] M. D'Angelica,et al. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy , 2010, Cancer.
[70] R. Manfredi,et al. [Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography]. , 2001, La Radiologia medica.
[71] Geoffrey E. Wile,et al. Magnetic resonance imaging of the liver: sequence optimization and artifacts. , 2010, Magnetic resonance imaging clinics of North America.
[72] Myeong-Jin Kim,et al. Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. , 2012, The British journal of radiology.
[73] P. Meier,et al. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. , 1999, The Journal of pharmacology and experimental therapeutics.
[74] K. Chandrakumaran,et al. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[75] M. Tillich,et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. , 1998, AJR. American journal of roentgenology.
[76] Tae Un Kim,et al. Significance of the “Delayed hyperintense portal vein sign” in the hepatobiliary phase MRI obtained with Gd‐EOB‐DTPA , 2012, Journal of magnetic resonance imaging : JMRI.
[77] B. Siegel,et al. Chemotherapy-Induced Normalization of FDG Uptake by Colorectal Liver Metastases Does Not Usually Indicate Complete Pathologic Response , 2007, Journal of Gastrointestinal Surgery.
[78] J A Brink,et al. Aortic and hepatic contrast medium enhancement at CT. Part I. Prediction with a computer model. , 1998, Radiology.
[79] B. Davidson,et al. Prospective study of contrast‐enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection , 2004, The British journal of surgery.
[80] S. Cowper,et al. Clinical and histological findings in nephrogenic systemic fibrosis. , 2008, European journal of radiology.
[81] J B Fowlkes,et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012 , 2012, Ultraschall in der Medizin.
[82] N. Hosten,et al. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. , 2012, Radiology.
[83] D. Gouma,et al. Prognostic Impact of Preoperative Imaging Parameters on Resectability of Hilar Cholangiocarcinoma , 2013, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.
[84] D. Iannitti,et al. Hepatocellular carcinoma and cholangiocarcinoma: an update , 2014, Expert review of gastroenterology & hepatology.
[85] J. Shindoh,et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] I. Floriani,et al. Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy , 2013, European Radiology.
[87] Doumit Daou,et al. Respiratory motion handling is mandatory to accomplish the high-resolution PET destiny , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[88] B. Gray,et al. Vascularization of small liver metastases , 1989, The British journal of surgery.
[89] S. Zangos,et al. Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography , 2006, European Radiology.
[90] G. Everson,et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[91] Steven A Curley,et al. Three Hundred and One Consecutive Extended Right Hepatectomies: Evaluation of Outcome Based on Systematic Liver Volumetry , 2009, Annals of surgery.
[92] K. Boudjema,et al. Liver Transplantation for Hepatocellular Carcinoma Without Preoperative Tumor Biopsy , 2008, Transplantation.
[93] J. Shindoh,et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. , 2013, Journal of the American College of Surgeons.
[94] L. Laasonen,et al. Preoperative assessment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging , 2005, Acta radiologica.
[95] R. Hunt,et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. , 2017, Journal of clinical gastroenterology.
[96] K. Lindor,et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis , 2008, Hepatology.
[97] G. Garcia‐Tsao,et al. Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program , 2009, The American Journal of Gastroenterology.
[98] I. Endo,et al. Importance of Complete Pathologic Response to Prehepatectomy Chemotherapy in Treating Colorectal Cancer Metastases , 2009, Annals of surgery.